Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis.
about
Ocular itch associated with allergic conjunctivitis: latest evidence and clinical managementEosinophils and mast cells as therapeutic targets in pediatric functional dyspepsiaPhase II drugs under investigation for allergic conjunctivitis.Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy.Conjunctival allergen provocation test : guidelines for daily practice.DS-70, a novel and potent α integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs
P2860
Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis.
@en
type
label
Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis.
@en
prefLabel
Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis.
@en
P2093
P2860
P356
P1476
Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis.
@en
P2093
Andrea Bedini
Gioia Carbonari
Monica Baiula
Samantha Deianira Dattoli
Santi Spampinato
P2860
P356
10.3389/FPHAR.2012.00203
P577
2012-12-26T00:00:00Z